# Amphastar Pharmaceuticals, Inc. (AMPH): MoatMap facts

As of 27 Oct 2026. Research data, not investment advice.

As of 27 Oct 2026, MoatMap's StockRank for Amphastar Pharmaceuticals, Inc. (AMPH) is 93/100, ranked against 24,000+ stocks in 35 markets (Quality 61, Value 73, Momentum 64, each scored against its sector).

- StockRank: 93/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 61, Value 73, Momentum 64: each a 0-100 percentile within Healthcare.
- Position: #1,761 overall, #193 in Healthcare.
- Listing: United States, NMS; Healthcare / Drug Manufacturers - Specialty & Generic.
- Last close: 25.47 USD on 26 Oct 2026.
- Insider filings, last 180 days: directors sold USD 764K.
- Buybacks, last 180 days: the company bought back USD 124.9M on 1 day.

Source: https://moatmap.ai/stock/AMPH
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker